These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17084184)

  • 1. Comments about the prospective randomized trial by Aoyama et al.
    Patchell RA; Regine WF; Renschler M; Loeffler JS; Sawaya R; Chin LS; Andrews DW
    Surg Neurol; 2006 Nov; 66(5):459-60. PubMed ID: 17084184
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiosurgery plus or minus whole brain radiation therapy for the treatment of brain metastases. An editorial comment.
    Lunsford LD; Flickinger JC
    Surg Neurol; 2006 Nov; 66(5):461-2. PubMed ID: 17084185
    [No Abstract]   [Full Text] [Related]  

  • 3. Same, better, or worse? Neurocognitive effects of radiotherapy for low-grade gliomas remain unknown.
    Brown PD; Cerhan JH
    Lancet Neurol; 2009 Sep; 8(9):779-81. PubMed ID: 19665932
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of postoperative radiotherapy after resection of a single brain metastasis. Combined analysis of 643 patients.
    Nieder C; Astner ST; Grosu AL; Andratschke NH; Molls M
    Strahlenther Onkol; 2007 Oct; 183(10):576-80. PubMed ID: 17896090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does extracorporeal circulation harm the brain?
    Smith WS; Mapstone M
    Neurology; 2005 Oct; 65(7):978-9. PubMed ID: 16217045
    [No Abstract]   [Full Text] [Related]  

  • 6. The Fox guarding the clinical trial: internal vs. external validity in randomized studies.
    Goodwin PJ; Pritchard KI; Spiegel D
    Psychooncology; 1999; 8(3):275. PubMed ID: 10390742
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for low-grade gliomas: emerging consensus on its benefits.
    Wen PY; DeAngelis LM
    Neurology; 2007 May; 68(21):1762-3. PubMed ID: 17515537
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of the primary tumor--key problem of cancer therapy].
    Holsti LR
    Duodecim; 2002; 118(8):779-86. PubMed ID: 12238192
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al.
    Korn EL; Hunsberger S; Freidlin B; Smith MA; Abrams JS
    Clin Trials; 2008; 5(4):364-5; author reply 365-6. PubMed ID: 18697851
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric brain tumor survivors, physicians, and researchers face long-term challenges.
    Twombly R
    J Natl Cancer Inst; 2009 Jul; 101(13):908-10. PubMed ID: 19549957
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive deficits in adult patients with brain tumours.
    Taphoorn MJ; Klein M
    Lancet Neurol; 2004 Mar; 3(3):159-68. PubMed ID: 14980531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in the treatment of brain metastases.
    Chang JE; Robins HI; Mehta MP
    Clin Adv Hematol Oncol; 2007 Jan; 5(1):54-64. PubMed ID: 17339829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapeutic alternatives for previously irradiated recurrent gliomas.
    Combs SE; Debus J; Schulz-Ertner D
    BMC Cancer; 2007 Aug; 7():167. PubMed ID: 17760992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses: in regard to Milano et al. (Int J Radiat Oncol Biol Phys 2009;73:832-837).
    Christodouleas JP; Marks LB
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1628; author reply 1628-9. PubMed ID: 19616752
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors affecting the prognosis of breast cancer patients with brain metastases.
    Saip P; Cicin I; Eralp Y; Kucucuk S; Tuzlali S; Karagol H; Aslay I; Topuz E
    Breast; 2008 Oct; 17(5):451-8. PubMed ID: 18455400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiation prevention of recurrences and metastases of malignant tumors].
    Ruderman AI
    Vopr Onkol; 1969; 15(10):15-20. PubMed ID: 5372746
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). In reply to Drs. Larson and Sahgal.
    Brown PD; Kee AY; Eshleman JS; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):316-7. PubMed ID: 19695444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.